NCT02398669View on ClinicalTrials.gov

A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Obesity
Interventions
DRUG

Lorcaserin hydrochloride

A single 10 mg dose of oral tablet formulation of lorcaserin hydrochloride will be administered with 240 mL of water.

Trial Locations (1)

92801

Anaheim Clinical Trials, Anaheim

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT02398669 - A Single Dose Pharmacokinetic Study of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age | Biotech Hunter | Biotech Hunter